TRPA1 Antagonist 1

TRPA1 Antagonist 1 is a potent, selective TRPA1 channel blocker with an IC50 of 8 nM. This compound is administered as a methylene phosphate prodrug, which is metabolized in vivo to release the active parent molecule. It is a valuable research tool for investigating TRPA1-mediated pathways in pain, inflammation, and respiratory models, both in cellular assays and animal studies.